Govt Should Examine Challenges with Emergency Approval Scheme Exposed by Shionogi Pill Review

Shionogi’s COVID-19 pill ensitrelvir failed to clear the second round of review by a key advisory panel on July 20. The session drew a great deal of attention since the drug is the first candidate for the application of Japan’s...read more